MERIGGIOLA, MARIA CRISTINA
 Distribuzione geografica
Continente #
AS - Asia 9.253
NA - Nord America 9.164
EU - Europa 6.778
SA - Sud America 532
AF - Africa 522
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 26.265
Nazione #
US - Stati Uniti d'America 9.051
VN - Vietnam 3.373
SG - Singapore 2.208
CN - Cina 1.901
IT - Italia 1.697
GB - Regno Unito 1.359
DE - Germania 793
SE - Svezia 631
HK - Hong Kong 609
FR - Francia 469
UA - Ucraina 382
BR - Brasile 380
IN - India 366
RU - Federazione Russa 353
IE - Irlanda 229
NL - Olanda 214
KR - Corea 159
JP - Giappone 153
TG - Togo 152
ZA - Sudafrica 133
FI - Finlandia 104
BG - Bulgaria 95
EE - Estonia 95
CI - Costa d'Avorio 88
AR - Argentina 72
JO - Giordania 71
CH - Svizzera 70
PH - Filippine 68
SC - Seychelles 62
CA - Canada 55
AT - Austria 49
BD - Bangladesh 48
TH - Thailandia 46
MX - Messico 41
BE - Belgio 38
PL - Polonia 36
TR - Turchia 36
ES - Italia 35
ID - Indonesia 35
NG - Nigeria 34
IQ - Iraq 30
RO - Romania 23
CZ - Repubblica Ceca 21
EC - Ecuador 21
SA - Arabia Saudita 21
TW - Taiwan 18
CL - Cile 17
GR - Grecia 17
PK - Pakistan 17
MY - Malesia 16
CO - Colombia 15
EG - Egitto 14
LT - Lituania 13
UZ - Uzbekistan 13
AL - Albania 9
IR - Iran 9
LB - Libano 9
AZ - Azerbaigian 8
KE - Kenya 8
PT - Portogallo 8
AU - Australia 7
UY - Uruguay 7
LV - Lettonia 6
MA - Marocco 6
NO - Norvegia 6
PE - Perù 6
TN - Tunisia 6
VE - Venezuela 6
IL - Israele 5
KZ - Kazakistan 5
PY - Paraguay 5
A2 - ???statistics.table.value.countryCode.A2??? 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
KG - Kirghizistan 4
MD - Moldavia 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
ET - Etiopia 3
HU - Ungheria 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
SN - Senegal 3
CR - Costa Rica 2
DK - Danimarca 2
HN - Honduras 2
HR - Croazia 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MN - Mongolia 2
OM - Oman 2
PA - Panama 2
QA - Qatar 2
SI - Slovenia 2
AF - Afghanistan, Repubblica islamica di 1
BF - Burkina Faso 1
BO - Bolivia 1
Totale 26.238
Città #
Singapore 1.512
Southend 1.123
Ashburn 1.097
Ho Chi Minh City 770
Fairfield 750
Chandler 741
Hanoi 714
Hong Kong 586
Santa Clara 522
Wilmington 410
San Jose 382
Woodbridge 378
Seattle 376
Hefei 327
Dong Ket 311
Houston 308
Princeton 294
Bologna 283
Beijing 265
Cambridge 259
Jacksonville 242
Ann Arbor 231
Dublin 229
Boardman 196
Lauterbourg 158
Los Angeles 152
Lomé 151
Milan 137
Nanjing 135
Tokyo 130
Turin 126
Seoul 125
Westminster 124
Dallas 111
Padova 107
Haiphong 103
Da Nang 95
Berlin 94
Sofia 94
Abidjan 88
New York 86
Helsinki 76
Redmond 75
Amman 70
Buffalo 66
Saint Petersburg 64
Frankfurt am Main 58
Rome 58
Bern 57
Shenyang 56
Council Bluffs 53
Jinan 53
São Paulo 53
Mülheim 51
Hải Dương 49
Quận Bình Thạnh 49
San Diego 49
Florence 48
Ha Long 45
Munich 45
Medford 42
Redondo Beach 42
Guangzhou 39
Nanchang 38
Shanghai 38
Biên Hòa 37
Changsha 34
Paris 34
Abeokuta 33
Brussels 32
Thái Nguyên 32
Vũng Tàu 32
Bengaluru 31
Hebei 31
London 31
Tianjin 31
Zhengzhou 31
Des Moines 30
Amsterdam 29
Orem 29
Can Tho 28
Falkenstein 28
Chicago 27
Ninh Bình 27
Phoenix 27
Falls Church 26
Bắc Ninh 25
Naples 25
Mahé 24
Mountain View 23
Verona 23
Bắc Giang 22
Hangzhou 22
Olalla 21
Redwood City 21
Điện Bàn 21
Kuban 20
Brooklyn 19
Dearborn 19
Jiaxing 19
Totale 16.540
Nome #
Sexuality and psychopathological aspects in premenopausal women with metabolic syndrome. 475
Safety of hormonal treatment in transgenders. 391
Prevalenza delle disfunzioni sessuali femminili nelle donne in menopausa con sindrome metabolica. 368
Tecniche di Riproduzione Assistita. 340
Long-term cross-sex hormone treatment is safe in transsexual subjects. 325
Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen. 313
A Randomized Double-Blind Placebo-Controlled Pilot Trial on the Effects of Testosterone Undecanoate Plus Dutasteride or Placebo on Muscle Strength, Body Composition, and Metabolic Profile in Transmen 290
Fetal cardiac defects and third-trimester maternal serum placental growth factor 278
Menopause affects pain depending on pain type and characteristics. 266
Endocrine care of transpeople part II. A review of cross-sex hormonal treatments, outcomes and adverse effects in transwomen. 265
Cognition, Mood and Sleep in Menopausal Transition: The Role of Menopause Hormone Therapy 251
Prevalence of Sexual Dysfunction among Postmenopausal Women with and without Metabolic Syndrome. 249
2D and 3D Ultrasound Examination of Labia Minora. 246
Completeness of exercise reporting among randomized controlled trials on pelvic floor muscle training for women with pelvic organ prolapse: A systematic review 243
Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review. 237
Reply to the Letter to the Editor: How Does Sleep Relate to Metabolic Syndrome in Women with Sexual Dysfunction? 235
A comparison of 5-year administration of cyproterone acetate or leuprolide acetate in combination with estradiol in transwomen 234
Androgen receptor expression in the human vagina under different physiological and treatment conditions 229
Effects of Three Different Testosterone Formulations in Female-to-Male Transsexual Persons. 228
Acceptability of an injectable male contraceptive regimen of norethisterone enanthate and testosterone undecanoate for men. 221
Neonatal hypoxic-ischemic encephalopathy in apparently low risk pregnancies: retrospective analysis of the last five years at the University of Bologna. 217
Body imaging and sexual behavior in lean women with polycystic ovary syndrome. 212
Ginecologia e Ostetricia. Seconda Edizione. 211
Accuracy of three-dimensional ultrasound in diagnosis and classification of congenital uterine anomalies. 209
Effects of long term high-dose testosterone administration on vaginal epithelium structure and estrogen receptor a and b expression of young women. 208
A novel circulating hormone of testis origin in humans 207
Bone mineral density, body composition and metabolic profiles in adult women with complete androgen insensitivity syndrome and removed gonads using oral or transdermal estrogens 204
Cervical length and risk of antepartum bleeding in women with complete placenta previa 203
Le malformazioni vaginali 202
Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review. 201
L'alterazione della funzione sessuale ha ripercussioni significativamente inferiori sul benessere psicofisico delle donne in menopausa rispetto alle donne in premenopausa. 201
Effetti metabolici della somministrazione di testosterone nei soggetti FtM (female to male) affetti da disforia di genere (D.I.G.). 197
Somministrazione di noretisterone enantato in combinazine con testosterone undecanoato per la contraccezione maschile 193
Hormonal replacement therapy in menopausal women with history of endometriosis: A review of literature 193
Testosterone decreases adiponectin levels in female to male transsexuals 191
Changes in Vaginal Physiology of Menopausal Women with Type 2 Diabetes 191
L'influenza della menopausa sulle caratteristiche della cefalea. 190
The impairment of sexual function is less distressing for menopausal than for premenopausal women. 189
A placebo controlled, randomized clinical trial using testosterone undecanoate with injectable norethisterone enanthate: effects on anthropometric, metabolic and biochemical parameters 189
Prevalence of metabolic syndrome and its components in women with and without pelvic organ prolapse and its association with prolapse severity according to the Pelvic Organ Prolapse Quantification system. 189
Cross-sex hormone administration changes pain in transsexual women and men. 187
Effects of ospemifene on vaginal epithelium of post-menopausal women. 187
Effect of long-term testosterone administration on the endometrium of female to male (FtM) transsexuals. 186
Valutazione dell'influenza dell'accesso chirurgico sulla sessualità nella donna isterectomizzata. 185
Impaired Lipid Profile is a Risk Factor for the Development of Sexual Dysfunction in Women 184
The impact of hormonal replacement treatment in postmenopausal women with uterine fibroids: A state-of-the-art review of the literature 184
Androgens and male contraception 182
A prospective study on sexual function and mood in female-to-male transsexuals during testosterone administration and after sex reassignment surgery. 181
Problematiche endocrine della disforia di genere 181
Short-term modification of sex hormones is associated with changes in ghrelin circulating levels in healthy normal-weight men. 180
Relationship between serum gonadotropins and spermatogenic suppression in men undergoing steroidal contraceptive treatment 179
Laparoscopic surgery for benign adnexal conditions under spinal anaesthesia: Towards a multidisciplinary minimally invasive approach 179
Vaginal Health in Menopausal Women 177
10th summit meeting consensus: recommendations for regulatory approval for hormonal male contraception. 176
Hysterectomy and Bilateral Salpingoovariectomy in a Transsexual Subject without Visible Scaring. 176
Carotid intima-media wall thickness is increased in FtM transsexuals treated with testosterone compared to normal control women. 174
Transvaginal Ultrasound and Doppler Features of Intraligamental Myomas 171
Contraccezione maschile: stato dell'arte. 169
Bone Mineral Density in Women Living with Complete Androgen Insensitivity Syndrome and Intact Testes or Removed Gonads. 169
Mental Health and Endocrine Telemedicine Consultations in Transgender Subjects During the COVID-19 Outbreak in Italy: A Cross-Sectional Web-Based Survey 169
Chest Wall Masculinization in Female-to-Male Transsexuals: Our Treatment Algorithm and Life Satisfaction Questionnaire 169
Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis 168
Structure of Epithelial and Stromal Compartments of Vulvar and Vaginal Tissue From Women With Vulvo-Vaginal Atrophy Taking Ospemifene. 168
Knowledge of genito-urinary syndrome of menopause among Italian gynecologists: the DIADEM survey 168
Norethisterone enanthate plus testosterone undecanoate for male contraception: effects of various injection intervals on spermatogenesis, reproductive hormones, testis, and prostate. 167
Cervical and hysteroscopic injection for identification of sentinel lymph node in endometrial cancer. 166
Update on male hormonal contraception 166
Bone health in transgender people: a narrative review 165
Accettabilita' e assenza di effetti sull'umore, sul comportamento e sulla funzione sessuale di un regime contraccettivo ormonale maschile 164
Testosterone Undecanoate (TU) administered alone or in combination with letrozole or dutasteride in female to male (FtM) transsexuals: hormonal and metabolic effects. 164
Treating VVA improves symptom severity and patient-reported outcomes: 6-month PEONY results 163
Vaginal metabolites in postmenopausal women with or without vulvo-vaginal atrophy at baseline and after ospemifeme and systemic hormone treatment 161
Reproductive and non-reproductive effects of testosterone undecanoate (TU) plus cyproterone acetate (CPA) or norethisterone enanthate (NETE) for male contraception. 160
Advances in male hormonal contraception. 159
Contraception across transgender 159
Laparoscopic treatment of interstitial twin pregnancy. 158
Chest-wall contouring in female to male transsexuals 157
Feasibility and safety of two different surgical routes for the eradication of recto-vaginal endometriosis with vaginal mucosa infiltration (Endo-Vag-r study) 155
Childhood maltreatment in subjects with male-to-female gender identity disorder. 154
Estrogens and testosterone change pain incidence and characteristics in MtF and FtM transsexuals. 153
Testosterone al femminile. 153
Prevalence and Psychopathological Determinants of Sexual Dysfunction and Related Distress in Women With and Without Multiple Sclerosis 150
Feminization of the face in male to female transsexuals 147
Repeated intramuscular injections of testosterone undecanoate (TU) in FtM transsexuals. 146
Small Variations in Crucial Steps of Tunel Assay Coupled to Flow Cytometry Greatly Affect Measures of Sperm DNA Fragmentation. 145
Effects of Testosterone Undecanoate (TU) Administered Alone or in Combination with Letrozole or Dutasteride in Female to Male (FtM) Transsexuals. 145
Feasibility, safety, and satisfaction of combined hysterectomy with bilateral salpingo-oophorectomy and chest surgery in transgender and gender non-conforming individuals 143
Effects of testosterone undecanoate (TU) administered alone or in combination with letrozole or dutasteride in female to male transsexuals (FtM): 142
Male hormonal contraception: a double-blind placebo-controlled study. 141
Hormonal and metabolic effects of testosterone undecanoate (TU) administered alone or in combination with letrozole or dutasteride in female to male (FtM) transsexuals. 141
The COVID-19 Pandemic Impact on the Psychophysical Health of Post-Menopausal Women: A Cross-Sectional Study 140
High dose testosterone (T) treatment has no adverse effects on the endometrium of Female to Male transsexuals (FtM). 140
Testosterone undecanoate and testosterone enanthate injections are both effective and safe in transmen over 5 years of administration. 140
Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis. 139
Dimensional profiles of male to female gender identity disorder: an exploratory research. 139
Urogenital and Reproductive Disorders 139
Sexual counterpart of hormonal male contraception. 137
Complete androgen insensitivity syndrome: From bench to bed 137
Associazione tra anticorpi antitiroide e abortivita' ripetuta (ABRI) 136
Dienogest alone or dienogest combined with estrogens in the treatment of ovarian endometriomas, that is the question. A retrospective cohort study 135
Totale 19.336
Categoria #
all - tutte 68.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.063


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021899 0 0 0 0 0 0 0 0 0 136 129 634
2021/20222.606 242 106 142 219 220 153 75 195 86 125 533 510
2022/20233.168 276 484 158 415 227 258 85 174 568 84 297 142
2023/20241.219 87 151 52 90 116 211 69 135 34 70 119 85
2024/20254.011 124 523 276 252 773 190 183 133 76 351 262 868
2025/20269.074 1.822 922 781 615 925 492 823 285 1.764 645 0 0
Totale 26.749